RENAL TREATMENT CENTERS - WEST, INC

Renal Treatment Centers - West, Inc. specializes in delivering therapeutic apheresis treatment services in clinical settings, with a focused expertise in onsite blood purification and plasma exchange procedures. The contractor provides specialized hematology and nephrology support services tailored to complex patient populations, utilizing advanced extracorporeal circulation systems and protocol-driven therapeutic interventions. Their technical capabilities encompass patient assessment, anticoagulation management, machine operation, adverse event monitoring, and compliance with AABB and ASFA guidelines for apheresis protocols. Key differentiators include operational precision in high-acuity environments, adherence to stringent sterile processing standards, and the ability to integrate seamlessly into existing VA clinical workflows without disrupting care continuity. The contractor maintains a consistent and deep relationship with the Department of Veterans Affairs, providing mission-critical apheresis services across multiple VA medical centers. Their work supports veterans requiring treatment for autoimmune disorders, neurologic conditions, and hematologic diseases, demonstrating an established pattern of reliable, on-site clinical service delivery within VA healthcare infrastructure. This sustained engagement reflects a trusted partnership built on clinical reliability and regulatory compliance. Operating under NAICS 621991—Blood and Organ Banks—the contractor’s industry focus is narrowly defined within therapeutic apheresis and blood component management, positioning them as a niche provider in specialized renal and immunologic care services. They do not engage in blood donation or storage but rather in the clinical application of apheresis technology for patient treatment, distinguishing them from general transfusion services. As a small business entity structured as 2L, Renal Treatment Centers - West, Inc. operates from Denver, Colorado, serving federal healthcare facilities with a concentrated geographic footprint. The company holds no formal government certifications but demonstrates regulatory alignment through consistent performance in highly compliant federal clinical environments.